Story perspectives

Phillies Retain Alvarado Amidst Suspension and Injury Struggles

11/6/2025

Summary

Story summary

The Philadelphia Phillies exercised a $9 million option to retain José Alvarado for 2026.
The 2025 season was difficult, including an 80-game suspension for a performance-enhancing drug and a left forearm strain.
Alvarado posted a 2.70 ERA before his suspension.
Phillies manager Rob Thomson said, "I’m bullish on Alvarado. I love his energy and his stuff."
The team aims to improve its bullpen after finishing 28th in whiff rate.

History

Historical Context

Major League Baseball's crackdown on performance-enhancing drugs intensified after the 2005 Congressional hearings, which highlighted rampant steroid use among players. In November 2005, MLB adopted stricter penalties, including a 50-game suspension for first-time offenders. This shift aimed to restore integrity to the sport, reflecting ongoing concerns about player health and competitive fairness amid the notorious "Steroid Era" that spanned the 1990s and early 2000s.

1 of 2

Story summary

The Philadelphia Phillies exercised a $9 million option to retain José Alvarado for 2026.
The 2025 season was difficult, including an 80-game suspension for a performance-enhancing drug and a left forearm strain.
Alvarado posted a 2.70 ERA before his suspension.
Phillies manager Rob Thomson said, "I’m bullish on Alvarado. I love his energy and his stuff."
The team aims to improve its bullpen after finishing 28th in whiff rate.

1 / 2